AC Immune (ACIU) Price to Sales (2016 - 2026)
AC Immune's Price to Sales was 10.93 in the quarter ended Jun 30, 2026, up 79.1% from 6.10 a year earlier but down 82.0% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Price to Sales (2016 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Price to Sales at AC Immune came in at 74.13, up 748.8% from the prior year.
- In earlier years, Price to Sales was 8.73 in the year ended Dec 31, 2024 (-71.0%), 30.10 in the year ended Dec 31, 2023 (-27.2%) and 41.35 in the year ended Dec 31, 2022.
- Quarterly Price to Sales has moved between 5.76 (the quarter ended Mar 31, 2025) and 288.60 (the quarter ended Jun 30, 2022) over five years.
- Compared with a year earlier, Price to Sales has increased for four straight quarters, with growth averaging 424.6% over the last five quarters.
- The best year-over-year quarter for Price to Sales over five years was the quarter ended Mar 31, 2026 (growth of 954.4%); the worst was the quarter ended Jun 30, 2025 (a decline of 92.5%).
- Per Business Quant data, ACIU's Price to Sales in the three quarters before the quarter ended Jun 30, 2026 was 60.78 (quarter ended Mar 31, 2026), 74.72 (quarter ended Dec 31, 2025) and 56.34 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | AC Immune | 276.74 Mn | 276.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.93 |
| Mar 31, 2026 | 60.78 |
| Dec 31, 2025 | 74.72 |
| Sep 30, 2025 | 56.34 |
| Jun 30, 2025 | 6.10 |
| Mar 31, 2025 | 5.76 |
| Dec 31, 2024 | 8.61 |
| Sep 30, 2024 | 10.95 |
| Jun 30, 2024 | 81.87 |
| Dec 31, 2022 | 41.87 |
| Sep 30, 2022 | 64.76 |
| Jun 30, 2022 | 288.60 |
| Dec 31, 2021 | 182.50 |
| Sep 30, 2021 | 142.47 |
| Dec 31, 2020 | 23.12 |
| Sep 30, 2020 | 22.04 |
| Jun 30, 2020 | 9.95 |
| Mar 31, 2020 | 10.14 |
| Dec 31, 2019 | 5.48 |
| Sep 30, 2019 | 2.63 |
API Access
AC Immune Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();